Novo and Anthropic announced today a collaboration to accelerate the development of new medicines and AI-driven software. The news landed hours after European Commission President Ursula von der Leyen spoke about the benefits of AI in health care — and days after tech bros warned there is a 10% likely existential threat to all humanity from super AI within the next decade. Anthopic also revealed last week scientists have tried to use Claude to develop bioweapons . The Danish pharma giant said it would use the American artificial intelligence company’s models and Claude Science to advance its research as it aims to become “the world’s most AI-driven healthcare company.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.